Literature DB >> 7042536

The preparation and cytotoxic properties of antibody-toxin conjugates.

P E Thorpe, W C Ross.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7042536     DOI： 10.1111/j.1600-065x.1982.tb00392.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  35 in total

Review 1.  Molecular recognition in antibodies and its application.

Authors:  M C Tedford; W H Stimson
Journal:  Experientia       Date:  1991-12-01

Review 2.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

3.  Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.

Authors:  E J Wawrzynczak; G J Watson; A J Cumber; R V Henry; G D Parnell; E P Rieber; P E Thorpe
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Readily available fluorescein isothiocyanate-conjugated antibodies can be easily converted into targeted phototoxic agents for antibacterial, antiviral, and anticancer therapy.

Authors:  S Devanathan; T A Dahl; W R Midden; D C Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 5.  Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors:  B P Ram; P Tyle
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

6.  Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins.

Authors:  M Izquierdo; M A Balboa; A Figuera; M López-Botet
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

7.  Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines.

Authors:  L Cattel; L Delprino; P Brusa; F Dosio; P M Comoglio; M Prat
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  In vitro and in vivo cytotoxic activity of native and ricin conjugated monoclonal antibodies to HBs antigen for Alexander primary liver cell carcinoma cells and tumours.

Authors:  J M Oladapo; A H Goodall; R de Koning; J Parmar; D Brown; H C Thomas
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

9.  Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution.

Authors:  J Zorzos; D V Skarlos; A A Epenetos; D Pectasides; P Koutsioumba; J Elemenoglou; A Bakiras; M Likourinas; K Dimopoulos
Journal:  Urol Res       Date:  1993

10.  Activation of human complement by mouse and mouse/human chimeric monoclonal antibodies.

Authors:  J Seino; P Eveleigh; S Warnaar; L J van Haarlem; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.